1. Home
  2. TVTX vs OI Comparison

TVTX vs OI Comparison

Compare TVTX & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • OI
  • Stock Information
  • Founded
  • TVTX 2008
  • OI 1903
  • Country
  • TVTX United States
  • OI United States
  • Employees
  • TVTX N/A
  • OI N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • OI Containers/Packaging
  • Sector
  • TVTX Health Care
  • OI Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • OI Nasdaq
  • Market Cap
  • TVTX 1.7B
  • OI 1.8B
  • IPO Year
  • TVTX N/A
  • OI N/A
  • Fundamental
  • Price
  • TVTX $20.02
  • OI $13.44
  • Analyst Decision
  • TVTX Strong Buy
  • OI Buy
  • Analyst Count
  • TVTX 14
  • OI 8
  • Target Price
  • TVTX $33.31
  • OI $15.88
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • OI 1.4M
  • Earning Date
  • TVTX 05-01-2025
  • OI 04-29-2025
  • Dividend Yield
  • TVTX N/A
  • OI N/A
  • EPS Growth
  • TVTX N/A
  • OI N/A
  • EPS
  • TVTX N/A
  • OI N/A
  • Revenue
  • TVTX $273,533,000.00
  • OI $6,505,000,000.00
  • Revenue This Year
  • TVTX $68.31
  • OI $1.19
  • Revenue Next Year
  • TVTX $55.65
  • OI $1.15
  • P/E Ratio
  • TVTX N/A
  • OI N/A
  • Revenue Growth
  • TVTX 75.65
  • OI N/A
  • 52 Week Low
  • TVTX $6.01
  • OI $9.23
  • 52 Week High
  • TVTX $25.29
  • OI $15.72
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 58.32
  • OI 69.43
  • Support Level
  • TVTX $19.65
  • OI $12.80
  • Resistance Level
  • TVTX $22.07
  • OI $13.49
  • Average True Range (ATR)
  • TVTX 1.11
  • OI 0.48
  • MACD
  • TVTX 0.31
  • OI 0.16
  • Stochastic Oscillator
  • TVTX 69.58
  • OI 98.08

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

Share on Social Networks: